Support the Epilepsy Foundation of North Carolina

Click here to donate to the Epilepsy Foundation

The US Food and Drug Administration (FDA) has approved another once-daily extended-release formulation of topiramate (Qudexy XR, Upsher-Smith Laboratories Inc),  In August 2013 the FDA had previously  approved an  oral once-daily extended-release topiramate product (Trokendi XR),  as well as an extended release oxcarbazepine (Supernus Pharmaceuticals). In October 2012, Fycompa (perampanel) manufactured by EISAI Pharmaceuticals was approved for treatment of partial onset seizures.